Healthpoint Biotherapeutics Signs Brazilian Distribution Agreement for Oasis Extracellular Matrix Product Line
- Wed, 6/13/12 - 10:33am
- 0 Comments
- 410 reads
Healthpoint Biotherapeutics (Fort Worth, TX) entered into a distribution agreement with Efe Consultoria & Importação Ltda to commercialize the OASIS® Extracellular Matrix product line in Brazil. OASIS® products are based on an extracellular matrix material derived from porcine small intestinal submucosa (SIS®), which is designed to support the body’s natural healing mechanisms in difficult-to-heal and chronic wounds. Both single and bi-layered versions of will be marketed in Brazil.
Visit http://www.healthpointbio.com for more information.